✦ LIBER ✦

A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes

✍ Scribed by Gjin Ndrepepa; Siegmund Braun; Julinda Mehilli; Kathrin Niemöller; Albert Schömig; Adnan Kastrati

Publisher: Springer
Year: 2006
Tongue: English
Weight: 257 KB
Volume: 96
Category: Article
ISSN: 1861-0684
DOI: 10.1007/s00392-006-0457-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Pharmacodynamic Evaluation o

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

✍ Jorge F. Saucedo; Henry K. Lui; Luis Garza; G. Jose Guerra; Mary V. Jacoski; Lis 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 179 KB

Prediction of clinical outcome in patien

Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels

✍ Rudolf Jarai; Nelly Iordanova; Robert Jarai; Ferenc Jarai; Annamaria Raffetseder 📂 Article 📅 2007 🏛 Springer Vienna 🌐 English ⚖ 241 KB

Utilization of catheterization and revas

Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade

✍ Glenn N. Levine; A. Michael Lincoff; James J. Ferguson III; Kenneth W. Mahaffey; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 1 views

Influence of abciximab on evolution of l

Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial

✍ Stefanie Schulz; Julinda Mehilli; Gjin Ndrepepa; Franz Dotzer; Michael Dommasch; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 257 KB